Skip to content
HowShorted

TENAX THERAPEUTICS, INC. short interest in 2019

In 2019, TENAX THERAPEUTICS, INC.'s disclosed short interest ran from 2.93% of shares outstanding on 15 Jan 2019 to 0.92% on 31 Dec 2019, a change of -2.01 percentage points. The year's high was 15.78% on 29 Mar 2019 and its low 0.58% on 13 Dec 2019, averaging 4.40% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.01 days on 15 May 2019. Full history: TENAX THERAPEUTICS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for TENAX THERAPEUTICS, INC. in 2019

2019 in figures

Start of year
2.93% (15 Jan 2019)
End of year
0.92% (31 Dec 2019)
Change
-2.01 pp
High
15.78% (29 Mar 2019)
Low
0.58% (13 Dec 2019)
Average
4.40%
Highest days to cover
5.01 (15 May 2019)
SEC filings marked
4

Every report in 2019

TENAX THERAPEUTICS, INC. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 20192.93%1.00
31 Jan 20191.26%1.00
29 Mar 201915.78%1.00
15 Apr 201914.52%2.0510-K filed
30 Apr 201913.07%4.70
15 May 201912.23%5.0110-Q filed
31 May 20194.91%2.50
14 Jun 20194.45%1.94
28 Jun 20194.32%2.86
15 Jul 20193.46%4.14
31 Jul 20192.45%1.75
15 Aug 20192.28%2.6510-Q filed
30 Aug 20192.69%1.05
13 Sep 20192.03%2.44
30 Sep 20191.49%3.49
15 Oct 20191.00%2.65
31 Oct 20190.85%1.26
15 Nov 20190.63%1.2210-Q filed
29 Nov 20190.63%1.72
13 Dec 20190.58%2.84
31 Dec 20190.92%1.18

See also: TENAX THERAPEUTICS, INC.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.